Confluent (CFLT)
(Delayed Data from NSDQ)
$20.90 USD
+0.48 (2.35%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $20.90 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$20.90 USD
+0.48 (2.35%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $20.90 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Zacks News
Compared to Estimates, Confluent (CFLT) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Confluent (CFLT) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Confluent (CFLT) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Confluent (CFLT) delivered earnings and revenue surprises of 20% and 2.39%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Are Options Traders Betting on a Big Move in Confluent (CFLT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Confluent (CFLT) stock based on the movements in the options market lately.
Confluent (CFLT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Confluent (CFLT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Confluent (CFLT) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Confluent (CFLT) delivered earnings and revenue surprises of 150% and 2.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Curious about Confluent (CFLT) Q1 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Confluent (CFLT) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
AppLovin (APP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
AppLovin (APP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Investors Need to Take Advantage of These 2 Business Services Stocks Now
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Confluent (CFLT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Confluent (CFLT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Automatic Data (ADP) to Report Q3 Earnings: What's in Cards?
by Zacks Equity Research
Automatic Data (ADP) third-quarter fiscal 2024 revenues are likely to have benefitted from growth in new bookings.
Want Better Returns? Don?t Ignore These 2 Business Services Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
These 2 Business Services Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for EUSA
Is Confluent (CFLT) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Confluent (CFLT) and Elastic (ESTC) have performed compared to their sector so far this year.
Compared to Estimates, Confluent (CFLT) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Confluent (CFLT) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Confluent (CFLT) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Confluent's (CFLT) fourth-quarter 2023 earnings and revenues are likely to increase year over year.
What Analyst Projections for Key Metrics Reveal About Confluent (CFLT) Q4 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of Confluent (CFLT) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Confluent (CFLT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Confluent (CFLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include Confluent, Pinterest, ICON and ImmunoGen
by Zacks Equity Research
Confluent, Pinterest, ICON and ImmunoGen are part of the Zacks Screen of the Week article.
Down -41.9% in 4 Weeks, Here's Why Confluent (CFLT) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Confluent (CFLT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
4 Stocks to Invest in for Remarkable Earnings Acceleration
by Tirthankar Chakraborty
Invest in stocks such as Confluent (CFLT), Pinterest (PINS), ICON (ICLR) and ImmunoGen (IMGN) for solid earnings acceleration.
Confluent (CFLT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Confluent (CFLT) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Confluent (CFLT) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Confluent (CFLT) delivered earnings and revenue surprises of 300% and 2.75%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Byrna Technologies Inc. (BYRN) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Byrna Technologies Inc. (BYRN) delivered earnings and revenue surprises of -333.33% and 1.21%, respectively, for the quarter ended August 2023. Do the numbers hold clues to what lies ahead for the stock?
Confluent (CFLT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Confluent (CFLT) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.